GSK snaps up IDRx for up to $1.15B
Britan-based pharmaceutical giant GSK has agreed to acquire 100% of the outstanding equity...
Read More
Category: Industry Trends
Transcarent paying $621M to acquire health benefits navigator Accolade
Transcarent has announced plans to acquire Accolade for $621 million, marking a significant step...
Read MorePfizer picks Triana Biomedicines to find Molecular Glues for Cancer
US pharmaceutical giant Pfizer announced a groundbreaking collaboration with Triana Biomedicines to develop Molecular Glue Degraders. The partnership aims to create multiple advanced therapies, including cancer. The...
Read MoreOncoC4 merged with AcroImmune
An all-stock transaction between OncoC4, a biopharmaceutical business in its late stages, and AcroImmune has been completed. OncoC4 strengthens its development by adding two critical drug candidates, AI-061, a PD-1/VEGF...
Read MoreCorroHealth Acquired Revenue Cycle Management Business from Navient
CorroHealth has finalized its acquisition of the healthcare revenue cycle management (RCM) business from Navient’s Xtend Healthcare, significantly expanding its capabilities in revenue cycle management consultancy and...
Read More